Cargando…
Occurrence and severity of non-occlusive mesenteric ischemia (NOMI) after cardiovascular surgery correlate with preoperatively assessed FGF-23 levels
PURPOSE: To evaluate the value of preoperatively assessed fibroblast growth factor 23 (FGF-23) levels and to correlate FGF-23 with angiographic findings in non-occlusive mesenteric (NOMI) ischemia using a standardized scoring system. MATERIALS AND METHODS: Between 2/2011 and 3/2012 a total of 865 pa...
Autores principales: | Stroeder, Jonas, Klingele, Matthias, Bomberg, Hagen, Wagenpfeil, Stefan, Buecker, Arno, Schaefers, Hans-Joachim, Katoh, Marcus, Minko, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549750/ https://www.ncbi.nlm.nih.gov/pubmed/28792535 http://dx.doi.org/10.1371/journal.pone.0182670 |
Ejemplares similares
-
MDCT-findings in patients with non-occlusive mesenteric ischemia (NOMI): influence of vasoconstrictor agents
por: Topolsky, Antoine, et al.
Publicado: (2023) -
A strategy for improving the prognosis of non‐occlusive mesenteric ischemia (NOMI): a single‐center observational study
por: Nakamura, Fumiko, et al.
Publicado: (2019) -
A single preoperative FGF23 measurement is a strong predictor of outcome in patients undergoing elective cardiac surgery: a prospective observational study
por: Speer, Timo, et al.
Publicado: (2015) -
Non-occlusive mesenteric ischemia (NOMI): evaluation of 2D-perfusion angiography (2D-PA) for early treatment response assessment
por: Becker, Lena S., et al.
Publicado: (2020) -
The role of multislice computed tomography (MSCT) angiography in the diagnosis and therapy of non-occlusive mesenteric ischemia (NOMI): Could MSCT replace DSA in diagnosis?
por: Kammerer, Sara, et al.
Publicado: (2018)